II

Inspire Investing Portfolio holdings

AUM $918M
1-Year Return 14.89%
This Quarter Return
-22.08%
1 Year Return
+14.89%
3 Year Return
+68.03%
5 Year Return
+142.65%
10 Year Return
AUM
$250M
AUM Growth
-$28.5M
Cap. Flow
+$34.5M
Cap. Flow %
13.77%
Top 10 Hldgs %
22.45%
Holding
855
New
487
Increased
123
Reduced
190
Closed
37

Sector Composition

1 Industrials 15.19%
2 Technology 13.79%
3 Healthcare 10.02%
4 Financials 7.41%
5 Consumer Discretionary 7.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TWTR
726
DELISTED
Twitter, Inc.
TWTR
$6K ﹤0.01%
+262
New +$6K
F icon
727
Ford
F
$45.5B
$5K ﹤0.01%
+1,056
New +$5K
PK icon
728
Park Hotels & Resorts
PK
$2.36B
$5K ﹤0.01%
+614
New +$5K
MD icon
729
Pediatrix Medical
MD
$1.44B
$4K ﹤0.01%
320
-7,218
-96% -$90.2K
BMY.RT
730
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$4K ﹤0.01%
+958
New +$4K
DISH
731
DELISTED
DISH Network Corp.
DISH
$4K ﹤0.01%
+185
New +$4K
AKRX
732
DELISTED
Akorn, Inc.
AKRX
$3K ﹤0.01%
+4,627
New +$3K
LFVN icon
733
LifeVantage
LFVN
$143M
$2K ﹤0.01%
+200
New +$2K
INO icon
734
Inovio Pharmaceuticals
INO
$140M
$1K ﹤0.01%
+10
New +$1K
IOVA icon
735
Iovance Biotherapeutics
IOVA
$861M
$1K ﹤0.01%
+18
New +$1K
SCHB icon
736
Schwab US Broad Market ETF
SCHB
$36.5B
$1K ﹤0.01%
+66
New +$1K
VSTM icon
737
Verastem
VSTM
$608M
$1K ﹤0.01%
+16
New +$1K
VWO icon
738
Vanguard FTSE Emerging Markets ETF
VWO
$99B
$1K ﹤0.01%
+17
New +$1K
ZN
739
DELISTED
Zion Oil & Gas, Inc.
ZN
$1K ﹤0.01%
+5,382
New +$1K
PRTY
740
DELISTED
Party City Holdco Inc.
PRTY
-87,381
Closed -$204K
ABBV icon
741
AbbVie
ABBV
$374B
0
ADNT icon
742
Adient
ADNT
$1.92B
$0 ﹤0.01%
+1
New
ALK icon
743
Alaska Air
ALK
$7.22B
$0 ﹤0.01%
+1
New
ARLP icon
744
Alliance Resource Partners
ARLP
$2.92B
-16,254
Closed -$176K
AROC icon
745
Archrock
AROC
$4.35B
-18,207
Closed -$183K
AXL icon
746
American Axle
AXL
$704M
-16,443
Closed -$177K
BDX icon
747
Becton Dickinson
BDX
$54B
0
BLUE
748
DELISTED
bluebird bio
BLUE
0
BN icon
749
Brookfield
BN
$100B
0
BMY icon
750
Bristol-Myers Squibb
BMY
$96B
0